Abstract:Objectives Proteomic profiling of serum is an emerging technique to identify new biomarkers indicative of disease severity and progression. Our study was to assess the use of surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify multiple serum protein biomarkers for early detection of laryngeal squamous cell carcinoma (LSCC), establish predictive model, and accurately distinguish LSCC patients with or without lymph node metastasis. Methods A cohort of 252 serum samples with LSCC ( n = 142) and normal control ( n = 110) were consented into this study. These serum samples were randomly divided into training set (including 89 LSCC patients at stages I–II and 65 normal controls, 30 LSCC patients with lymph node metastasis) and blind testing set (including 53 LSCC patients at stages III–IV and 45 normal controls). Serum protein profiles on weak cationic exchange (WCX2) were performed by SELDI-TOF MS and then analyzed by Biomarker Wizard software. The Decision Tree classification algorithm and blind validation were determined by Biomarker Pattern Software (BPS). Results A panel of 18 biomarkers ranging 2–30 kDa was selected based on their collective contribution to the optimal separation between stages I–II LSCC patients and healthy controls. Among them, one candidate protein peak with an m/z value of 4,176 Da was selected to establish predictive model by BPS with sensitivity of 86.52% and specificity of 84.62%. The ability to detect LSCC patients was evaluated using blinding test data in stages III and IV cancer patients. A sensitivity of 84.91% and specificity of 82.22% were validated in blind testing set. Meanwhile 14 potential biomarkers could differentiate LSCC patients with or without lymph node metastasis ( P < 0.05). Conclusions The high sensitivity and specificity achieved by the serum protein biomarkers show great potential for the early detection of LSCC. SELDI-TOF MS serum profiling also is able to distinguish LSCC patients with or without lymph node metastasis.

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma

Identification of Serum Biomarkers for Nasopharyngeal Carcinoma by Proteomic Analysis.

Detection of Serum Protein Biomarkers by Surface Enhancedlaser Desorption Ionization Time of Flight Mass Spectrometry in Patients of Nasopharyngeal Carcinoma

[A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma]

Highly Efficient Blood Protein Analysis Using Membrane Purification Technique and Super-Hydrophobic SERS Platform for Precise Screening and Staging of Nasopharyngeal Carcinoma

Identification of Candidate Biomarkers for the Early Detection of Nasopharyngeal Carcinoma by Quantitative Proteomic Analysis.

[Serum Diagnosis of Head and Neck Squamous Cell Carcinoma Using Surface-Enhanced Desorption Ionization Mass Spectrometry and Artificial Neural Network Analyses].

Noninvasive Detection of Nasopharyngeal Carcinoma Based on Saliva Proteins Using Surface-Enhanced Raman Spectroscopy

Serum Metabolic Fingerprinting to Detect Human Nasopharyngeal Carcinoma Based on Gas Chromatography-Mass Spectrometry and Partial Least Squares-Linear Discriminant Analysis

[Establishment of a Specific Serum Proteomic Profile Model of Nasopharyngeal Carcinoma by MALDI-TOF MS].

Extensive Serum Biomarker Analysis in Patients with Nasopharyngeal Carcinoma.

SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis

Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma

Diagnosis of nasopharyngeal carcinoma from serum samples using hyperspectral imaging combined with a chemometric method.

Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection

Molecular separation-assisted label-free SERS combined with machine learning for nasopharyngeal cancer screening and radiotherapy resistance prediction

Nasopharyngeal carcinoma cell screening based on the electroporation-SERS spectroscopy

Comparative Serum Proteomic Analysis Involving Liver Organ-Specific Metastasis-Associated Proteins Of Nasopharyngeal Carcinoma

Application of Seldi-Tof-Ms Coupled with an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer

[Surface Enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry Profiling of Serum in Detection of Laryngeal Squamous Cell Carcinoma and the Progression to Lymph Node Metastasis].

Screening for Nasopharyngeal Carcinoma Antigens That Induce Humoral Immune Response by Serological Proteomics Analysis